Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students
PLOS ONE · 11.01.2023 · 18 (1) · e0280287
DOI: 10.1371/journal.pone.0280287 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 11.01.2023. Verfasst von Samuel R Bunting und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neuroscience, The University of Chicago Medicine, Chicago, Illinois, United States of America. Hauptthemen laut MEDLINE: Papillomavirus Infections, Students, Medical, Papillomavirus Vaccines, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Gilead Sciences, National Institute on Drug Abuse.
Abstract (Originalsprache)
Human papillomavirus (HPV) vaccination is a well-established and successful tool for preventing HPV-related cancers. However, vaccine uptake remains low, influenced by patient hesitancy around safety concerns and little opportunity to discuss the vaccine with trusted healthcare providers. We conducted a national, cross-sectional study of allopathic and osteopathic medical students regarding knowledge of HPV vaccination guidelines March-April 2021. Analysis sought to identify gaps in knowledge as well as demographic and academic correlates of knowledge. A total of 718 students participated (response rate = 50.8%). While 92.8% of participants identified the connection between HPV and cervical cancer, lower percentages associated HPV with vaginal/vulvar (67.7%), anal (63.3%), and penile (53.9%) cancers. Low percentages of participants correctly identified age of HPV vaccine eligibility (33.3%) and how many doses are needed for full protection (48.1%). This study identifies specific knowledge gaps in medical students’ training on HPV-related cancers and HPV vaccination guidelines. Through addressing these gaps, we may improve HPV vaccine uptake and decrease the incidence of HPV-related cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neuroscience, The University of Chicago Medicine, Chicago, Illinois, United States of America.
- Pritzker School of Medicine, The University of Chicago Medicine, Chicago, Illinois, United States of America.
- Department of Psychology, College of Health Professions, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
- Department of Medicine, Section of Infectious Diseases and Global Health, The University of Chicago Medicine, Chicago, Illinois, United States of America.
- Department of Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
ORCID-Profile: Samuel R Bunting
Förderung
- NIDA NIH HHS
- Gilead Sciences
- National Institute on Drug Abuse
Zitieren
APA
Bunting, S. R., Morris, S., Chael, J., Feinstein, B. A., Hazra, A., & Garber, S. S. (2023). Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students. PLOS ONE, 18(1), e0280287. https://doi.org/10.1371/journal.pone.0280287
Vancouver
Bunting SR, Morris S, Chael J, Feinstein BA, Hazra A, Garber SS. Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students. PLOS ONE. 2023;18(1):e0280287. doi:10.1371/journal.pone.0280287
BibTeX
@article{Bunting2023,
author = {Bunting, Samuel R and Morris, Samantha and Chael, Julia and Feinstein, Brian A and Hazra, Aniruddha and Garber, Sarah S},
title = {Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {1},
pages = {e0280287},
doi = {10.1371/journal.pone.0280287}
}
EUVIMED